Solv Wellness Appoints Dr. Christine Vaccaro as Its First Chief Medical Officer

Solv Wellness has named Dr. Christine Vaccaro, DO, FACOG, MSCP, as its first Chief Medical Officer, effective immediately. The Atlanta-based women's health company announced the appointment on October 14, 2026, according to PR Newswire. Dr. Vaccaro, a double board-certified urogynecologist and sexual medicine specialist, will advise Solv Wellness on its menopause education strategy and support educational initiatives for patients and healthcare professionals.

Dr. Vaccaro's Role at Solv Wellness

As Chief Medical Officer, Dr. Vaccaro will advise Solv Wellness's menopause education strategy, contribute to patient and clinician resources, and represent the company in select media, speaking, and educational programs. Her work will focus on helping women and clinicians understand their options, ask informed questions, and make evidence-based health decisions, extending the work the company has focused on since 2010.

Dr. Vaccaro is a fellowship-trained urogynecologist and reconstructive pelvic surgeon who is double board-certified by the American Board of Obstetrics and Gynecology and has advanced training in sexual medicine. She graduated from the United States Military Academy at West Point and spent 30 years in the U.S. Army, retiring at the rank of colonel after serving as Fellowship Program Director and Service Chief of Urogynecology and Reconstructive Pelvic Surgery at Walter Reed National Military Medical Center. She practices in Bethesda, Maryland, with Dr. Rachel Rubin.

Terri Wade, co-founder and CEO of Solv Wellness, said, "Women can spend more than a third of their lives after the menopause transition, yet too many are still expected to navigate it without real answers and solutions." Dr. Vaccaro said, "Women deserve a full menu of options, delivered compassionately."

The appointment comes amid a menopause education gap. Fewer than one in three U.S. OB/GYN residency programs offer a dedicated menopause curriculum, and only about half of women going through menopause have consulted a health professional about it.

Solv Wellness's Recent Moves

According to akta.pro company records, Solv Wellness partnered with registered dietitian Mia Syn, MS, RDN, in June 2026 during National Women's Health Month to elevate science-backed menopause support and drive education-led acquisition. In April 2026, the company launched the "Solv Wellness Essentials" line, including Hot Flash Relief, Joint Support, and Urinary Health, expanding from a clinical-strength UTI and vaginal-health specialist into a broader daily non-hormonal supplement portfolio for perimenopause and menopause. In 2026, Solv Wellness secured FDA clearance for Via as a non-hormonal vaginal moisturizer for safe, everyday use, distinguishing it from OTC lubricants and supporting reimbursement and clinical-channel positioning.

Solv Wellness is a privately held, Atlanta-based direct-to-consumer supplement company founded in 2010. Its leadership includes Terri Wade as co-founder and CEO, Kevin Wade as co-founder and EVP of Clinical Development, and Sophie Fletcher, M.D., as Medical Advisory Board Chair. The company's products include GennaMD, Via, Māge, and the Essentials line. Solv Wellness describes its work in women's midlife health at solvwellness.com.